IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

SAFC Partners with Pfenex to Codevelop Biopharmaceuticals (update)

7:45 AM MDT | June 8, 2011 | Alex Scott

Pfenex (San Diego), a pioneer in protein expression systems, has entered into a non-exclusive partnership with Sigma-Aldrich Fine Chemicals (SAFC) for the manufacture of therapeutic recombinant proteins. Under the agreement, Pfenex will engineer production strains and processes for SAFC’s contract manufacturing customers. Additionally, the companies plan to work together to introduce conjugate vaccines. The project would combine Pfenex’s expertise in the manufacture of vaccine components with SAFC’s expertise and facilities for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa